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Although the attention of the world and the global health community specifically is deservedly focused on the COVID-19 pandemic, other
determinants of health continue to have large impacts and may also interact with COVID-19. Air pollution is one crucial example.
Established evidence from other respiratory viruses and emerging evidence for COVID-19 specifically indicates that air pollution alters re-
spiratory defense mechanisms leading to worsened infection severity. Air pollution also contributes to co-morbidities that are known to
worsen outcomes amongst those infected with COVID-19, and air pollution may also enhance infection transmission due to its impact on
more frequent coughing. Yet despite the massive disruption of the COVID-19 pandemic, there are reasons for optimism: broad societal
lockdowns have shown us a glimpse of what a future with strong air pollution measures could yield. Thus, the urgency to combat air pol-
lution is not diminished, but instead heightened in the context of the pandemic.
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Problem
Air pollution is a major contributor to the global burden of disease,
with an estimated 12% of all deaths in 2019 (While other estimates
exist and each have their uncertainties, all estimates of attributable
disease burden are large and high-ranking in comparison to tradition-
al and more widely recognized CVD risk factors.) attributable to out-
door and household (Household air pollution is mainly a concern in
low income countries where polluting fuels (coal, wood, agricultural
residue, animal dung) are used for cooking and heating.) air pollu-
tion.1 While the impacts of air pollution on respiratory diseases is
widely recognized, 50% of the estimated 6.7 million deaths
attributable to air pollution in 2019 are due to cardiovascular dis-
eases.1 Globally, nearly 20% of cardiovascular disease deaths were at-
tributable to air pollution. Further, air pollution was the 4th highest
ranking risk factor for mortality, with more attributable deaths than
high LDL cholesterol, high body-mass index, physical inactivity, or al-
cohol use (Figure 1).
Globally air pollution contributes to an average loss of life expect-
ancy of 20 months, nearly as high as that for tobacco use (22 months),
with losses of two point five years in South Asia.2 Despite increasing
awareness of the impact of air pollution on population health, appre-
ciation of air pollution as a modifiable risk factor is still limited
amongst health care providers. With this joint opinion, and in
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accordance with the Sustainable Development Goals, the WHF,
AHA, ESC and ACC call for action in research and policy develop-
ment at a global scale. Further, we aim to generate awareness about
the impact of air pollution on cardiovascular disease as a means to-
wards reaching the World Heart Federation Goal of a 25% reduction
in premature cardiovascular mortality by 2025.
Air pollution and CVD – evidence
Air pollution is a complex and dynamic mixture of numerous com-
pounds in gaseous and particle form, originating from diverse sour-
ces, subject to atmospheric transformation and varying over space
and time. Three common air pollutants, particulate matter (PM),
ozone and nitrogen dioxide (NO2), are the focus of most monitoring
programs, communication efforts,3 health impact assessments, and
regulatory efforts.
Evidence for impacts on cardiovascular disease is most consistent
for PM, which is responsible for the vast majority of the disease bur-
den via its impacts on ischemic heart disease,4–6 and stroke,7 as well
as lung cancer, COPD, lower respiratory infections, Type 2 diabetes,
pregnancy outcomes and related infant mortality.8 Time series stud-
ies conducted in hundreds of urban areas globally indicate a consist-
ent association between short-term variability in PM and
cardiovascular disease deaths,9 while large cohort studies from both
high and lower income settings demonstrate increased cardiovascu-
lar disease incidence and mortality in association with PM levels.10
Further, PM air pollution has been associated with progression of ath-
erosclerosis.11 Ozone is mainly associated with exacerbation of re-
spiratory disease, with COPD incidence and mortality and with
metabolic effects. NO2 is often used as an indicator of traffic-related
air pollution. Chronic exposure to NO2 is associated with incident
childhood asthma while short-term variability is associated with ex-
acerbation of asthma and increased daily mortality counts.
A Scientific Statement from the American Heart Association
provides a detailed description of the pathophysiologic mecha-
nisms through which PM triggers cardiovascular events.4 Figure 2
summarises the likely dominant pathways including activation of
oxidative stress/inflammation and autonomic imbalance, as well
as translocation of components of the PM mixture (ultrafine
particles or specific constituents) into the systemic circulation.4
In turn, these alterations promote both subclinical cardiovascu-
lar disease (myocardial remodelling, atherosclerosis progression,
systemic and pulmonary hypertension, enhanced vasoconstric-
tion and coagulation) and thrombotic and non-thrombotic acute
cardiovascular events (acute coronary syndromes, decompen-
sated heart failure, stroke, life-threatening arrhythmias).4,5,12 The
AHA statement suggests the existing evidence is consistent with
Figure 1 Ranking of air pollution relative to other leading risk factors for global mortality. Mortality risk factors, Both sexes, all ages, 2019. Institute
for Health Metrics and Evaluation. (Adapted from Institute for Health Metrics and Evaluation, 2020).








































.a causal relationship between PM exposure and cardiovascular
morbidity and mortality.
More recently, the European Society of Cardiology expert pos-
ition paper updated the observational and mechanistic evidence and
identified air pollution as one of several major modifiable risk factors
relevant to the prevention and management of cardiovascular dis-
ease.5 The ESC paper identified a need for additional research regard-
ing the role of air pollution in relation to hypertension and incident
heart failure. This position paper also highlighted the role of health
professionals, including cardiologists, in counselling their patients on
the risks of air pollution while also supporting educational and policy
initiatives to reduce air pollution exposure.
Opportunity for global impact
The threats posed by air pollution are substantial. Approximately
seven billion persons (92% of the global population), live in areas
where the WHO Annual Air Quality Guideline for PM2.5 is
exceeded and three point six billion people (47% of the global popu-
lation) are exposed to household air pollution from the use of solid
fuels for cooking. Recent research also indicates that air pollution
impacts cardiovascular health even at very low levels below current
WHO guidelines and most national standards.13 Further, climate
change is leading to increased frequency and severity of wildfires,
which leads to large smoke episodes and associated health impacts
affecting major metropolitan areas.14
Despite these challenges, given its near-ubiquitous exposure, air
pollution reduction offers a powerful opportunity to equitably re-
duce cardiovascular disease. Experience also indicates a clear path
forward. In the US, reductions in PM concentrations resulting from a
diverse array of regulatory actions and technologies were responsible
for up to 15% of the increase in US life expectancy observed over the
past several decades.15,16 Similarly, programs such as India’s Pradhan
Mantri Ujjwala Yojana have made clean cooking fuels accessible to
millions of households,17 helping to reduce inequalities in non-
communicable diseases.
Addressing the challenge: The
role of cardiac organizations,
societies, and foundations
The WHF, ACC, AHA, and ESC are united in our commitment to re-
search, advocacy, and education to reduce the impacts of air
Figure 2 Biological pathways linking air pollution with cardiovascular disease. Mechanisms of cardiovascular disease attributable to air pollution
exposures. (Adapted from Rajesh Vedanthan and Michael Hadley, 2019).













































































..pollution on cardiovascular health. Specifically, we will advocate for
further research on cardiovascular disease and air quality,
disseminating findings to our memberships and via other activ-
ities, such as World Heart Day. We will also work to educate and
raise awareness among health care providers on the importance
of reducing air pollution and the cardiovascular benefits of air pollu-
tion mitigation. We will work with senior decision-makers in national,
regional and global governmental institutions to make air pollution
related heart disease a priority and to identify interventions to reduce
air pollution and its impact on NCDs. Finally, we will work with our
members to increase the development and use of clinical guidelines
on air pollution and cardiovascular disease to ensure clinicians are
educated on the topic. In addition, we will strive to provide presen-
tations on the links between air pollution and cardiovascular disease
at our respective congresses, engagements, and events.
Structural actions to mitigate pollution emissions are ultimately ne-
cessary to reduce harmful exposures. Before mitigation is achieved,
health care providers can play several important roles. First, clinicians
can advocate for air pollution mitigation as a health measure. Second,
clinicians can provide patients with personal measures to reduce
exposures and associated risk at the individual level. For example, use
of room air filtration can provide substantial improvements in PM lev-
els within residences, schools and workplaces, with some evidence
indicating improvements in blood pressure and measures of inflam-
mation.18 Third, health care providers can integrate air pollution into
disease management approaches. Communication tools such as vari-
ous air quality indices focused on short-term variation in air quality
can help patients adjust activities when air quality is poor.19 Detailed
air pollution maps that provide information on long-term exposures
and their impacts at neighborhood scales can also be used to target
CVD treatment,20 exposure reduction, and efforts to address other
behavioural risks contributing to CVD in those living in locations with
highest exposures.21 Finally, the health sector as a whole, which bears
the impact of air pollution, can provide much-needed support for
ministries of environment, energy, and transportation, which are
traditionally responsible for mitigation efforts.
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